Thank you to all the meeting organizers, presenters, moderators, and participants who attended the 2026 I-SCORE Meeting on March 26th and March 27th! With 79 in person attendants and 102 virtual attendants, this meeting provides a great opportunity for information-sharing and collaboration between DCP staff, program staff, and Consortia/CP-CTNet members. Highlights from the program include:
- Dr. Leslie Ford, Associate Director for Clinical Research at NCI, kicked off the meeting and welcomed participants and presenters to I-SCORE 2026.
- Dr. Philip Castle, Director of the Division of Cancer Prevention, presented his vision for cancer prevention.
- Dr. Goli Samimi, Director, Cancer Prevention Clinical Trials Network (CP-CTNet) provided an update on the CP-CTNet Program activities.
- Amy Bartosch, Branch Chief, Office of Grants Administration (OGA), provided on overview of the OGA Department.
The Keynote Speaker was Dr. Christina Curtis, Professor of Medicine, Genetics, and Biomedical Data Science, Senior Vice Chair of Research in the Department of Medicine and Director of Artificial Intelligence and Cancer Genomics, Stanford University.
The following speakers gave Clinical Trial Reports and Lessons Learned:
- Dr. Eduardo Vilar-Sanchez, MD Anderson
- Dr. Jason Willis , MD Anderson
- Dr. Seema Khan, Northwestern University
- Dr. Ju Dong Yang, Cedars-Sinai (Northwestern University LAO)
- Dr. Patricia Thompson, University of Arizona
- Dr. Malvi Savani, University of Arizona
- Dr. Scott Schuetze, University of Michigan
- Dr. Lee Jones, City of Hope (University of Michigan LAO)
- Dr. Lisa Barroilhet, University of Wisconsin
- Dr. David Weinberg, Gox Chase Cancer Center (University of Wisconsin LAO)
- Dr. Scott Waldman, Thomas Jefferson University (University of Wisconsin LAO)
A Scientific Session highlighting cross-cutting topics was presented by:
- Dr. Eduardo Vilar-Sanchez, MD Anderson (Immunoprevention)
- Dr. Nora Disis, University of Washington (Immunoprevention)
The following speakers presented on CP-CTNet Operations:
- Dr. Jens Eickhoff, DMASC, University of Wisconsin-Madison
- Sue Siminski, DMASC, Frontier Science
- Troy Budd, NCI
- Dr. Brian Cholewa, NCI
The following speakers presented on Cross-Network Studies:
- Dr. Ajay Bansal, University of Kansas (CP-CTNet Cross-Network Study)
- Dr. Edward Messing, University of Rochester (CP-CTNet Cross-Network Study)
- Dr. Seema Khan, Northwestern University (CP-CTNet Cross-Network Study)
A Scientific Session highlighting cross-cutting topics involving low-dose Tamoxifen was discussed by a panel of the following experts:
- Dr. Brandy Heckman-Stoddard, NCI (Low-dose Tamoxifen)
- Dr. Andrea De Censi, Champalimaud Foundation (Low-dose Tamoxifen)Dr. Carol Fabian, University of Kansas (Low-dose Tamoxifen)
- Dr. Bruce Kimler, University of Kansas (Low-dose Tamoxifen)
- Dr. Lauren Nye, University of Kansas (Low-dose Tamoxifen)
- Dr. Seema Khan, Northwestern University (Low-dose Tamoxifen)
A Scientific Session highlighting cross-cutting topics involving Metformin was discussed by a panel of the following experts:
- Dr. Ed Sauter, NCI (Metformin)
- Dr. Sai Yendamuri, Roswell Park (Metformin)
- Dr. J. Silvio Gutkind, UC San Diego (Metformin)
- Dr. Scott Lippman, UC San Diego (Metformin)
- Dr. Emma Barber, Northwestern University (Metformin)
- Dr. Andrea De Censi, Champalimaud Foundation (Metformin)
The feedback provided after the meeting was positive with many expressing appreciations for the planning team as well as for the meeting content and speaker presentations. View the agenda from this meeting.
We are looking forward to next year’s I-SCORE Meeting which will be held on March 18, 2027 to March 19, 2027. Check the Meetings and Events page for upcoming information regarding the 2027 meeting when it becomes available!